{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:06:23Z","timestamp":1782749183653,"version":"3.54.5"},"reference-count":58,"publisher":"American Society of Hematology","issue":"5","license":[{"start":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T00:00:00Z","timestamp":1703116800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,12]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Aberrant micro-RNA (miRNA) expression profiles have been associated with disease progression and clinical outcome in pediatric cancers. However, few studies have analyzed genome-wide dysregulation of miRNAs and messenger RNAs (mRNAs) in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL). To identify novel prognostic factors, we comprehensively investigated miRNA and mRNA sequencing (miRNA-seq and mRNA-seq) data in pediatric BCP-ALL samples with poor outcome. We analyzed 180 patients, including 43 matched pairs at diagnosis and relapse. Consensus clustering of miRNA expression data revealed a distinct profile characterized by mainly downregulation of miRNAs (referred to as an miR-low cluster [MLC]). The MLC profile was not associated with any known genetic subgroups. Intriguingly, patients classified as MLC had significantly shorter event-free survival (median 21 vs 33\u00a0months; log-rank P\u00a0= 3\u00a0\u00d710\u22125). Furthermore, this poor prognosis was retained even in hyperdiploid ALL. This poor prognostic MLC profiling was confirmed in the validation cohort. Notably, non-MLC profiling at diagnosis (n\u00a0= 9 of 23; Fisher exact test, P\u00a0= .039) often changed into MLC profiling at relapse for the same patient. Integrated analysis of miRNA-seq and mRNA-seq data revealed that the transcriptional profile of MLC was characterized by enrichment of MYC target and oxidative phosphorylation genes, reduced intron retention, and low expression of DICER1. Thus, our miRNA-mRNA integration approach yielded a truly unbiased molecular stratification of pediatric BCP-ALL cases based on a novel prognostic miRNA signature, which may lead to better clinical outcomes.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2023011583","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T16:07:20Z","timestamp":1703174840000},"page":"1258-1271","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":9,"title":["RNA-seq\u2013based miRNA signature as an independent predictor of relapse in pediatric B-cell acute lymphoblastic leukemia"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6935-5120","authenticated-orcid":false,"given":"Hirohito","family":"Kubota","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7617-1672","authenticated-orcid":false,"given":"Hiroo","family":"Ueno","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2708-3876","authenticated-orcid":false,"given":"Keiji","family":"Tasaka","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3487-3307","authenticated-orcid":false,"given":"Tomoya","family":"Isobe","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"},{"name":"3Department of Hematology, Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8930-3539","authenticated-orcid":false,"given":"Satoshi","family":"Saida","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2932-4960","authenticated-orcid":false,"given":"Itaru","family":"Kato","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-2011","authenticated-orcid":false,"given":"Katsutsugu","family":"Umeda","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3683-4472","authenticated-orcid":false,"given":"Mitsuteru","family":"Hiwatari","sequence":"additional","affiliation":[{"name":"2Department of Pediatrics, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan"},{"name":"4Department of Pediatrics, School of Medicine, Teikyo University, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2245-6554","authenticated-orcid":false,"given":"Daiichiro","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"5Department of Hematology and Oncology, Hyogo Prefectural Kobe Children Hospital, Hyogo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5727-4470","authenticated-orcid":false,"given":"Toshihiko","family":"Imamura","sequence":"additional","affiliation":[{"name":"6Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4893-5414","authenticated-orcid":false,"given":"Nobuyuki","family":"Kakiuchi","sequence":"additional","affiliation":[{"name":"7Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"},{"name":"8The Hakubi Center for Advanced Research, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6526-0992","authenticated-orcid":false,"given":"Yasuhito","family":"Nannya","sequence":"additional","affiliation":[{"name":"7Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"},{"name":"9Division of Hematopoietic Disease Control, Institute of Medical Science, The University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7778-5374","authenticated-orcid":false,"given":"Seishi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"7Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan"},{"name":"10Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan"},{"name":"11Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3136-5670","authenticated-orcid":false,"given":"Hidefumi","family":"Hiramatsu","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2452-6520","authenticated-orcid":false,"given":"Junko","family":"Takita","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Graduate School of Medicine, Kyoto University, Kyoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2024,3,5]]},"reference":[{"issue":"9","key":"2024031115352833700_bib1","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1038\/s41588-022-01159-z","article-title":"The genomic landscape of pediatric acute lymphoblastic leukemia","volume":"54","author":"Brady","year":"2022","journal-title":"Nat Genet"},{"issue":"4","key":"2024031115352833700_bib2","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1158\/2643-3230.BCD-20-0229","article-title":"Clinical significance of novel subtypes of acute lymphoblastic leukemia in the context of minimal residual disease\u2013directed therapy","volume":"2","author":"Jeha","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"20","key":"2024031115352833700_bib3","doi-asserted-by":"crossref","first-page":"5165","DOI":"10.1182\/bloodadvances.2019001307","article-title":"Landscape of driver mutations and their clinical impacts in pediatric B-cell precursor acute lymphoblastic leukemia","volume":"4","author":"Ueno","year":"2020","journal-title":"Blood Adv"},{"issue":"3","key":"2024031115352833700_bib4","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1016\/S1470-2045(19)30031-2","article-title":"Comparative features and outcomes between paediatric T-cell and B-cell acute lymphoblastic leukaemia","volume":"20","author":"Teachey","year":"2019","journal-title":"Lancet Oncol"},{"issue":"7","key":"2024031115352833700_bib5","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1182\/blood-2016-03-704973","article-title":"Integration of genetic and clinical risk factors improves prognostication in relapsed childhood B-cell precursor acute lymphoblastic leukemia","volume":"128","author":"Irving","year":"2016","journal-title":"Blood"},{"issue":"5","key":"2024031115352833700_bib6","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/bjh.12442","article-title":"Predicting relapse risk in childhood acute lymphoblastic leukaemia","volume":"162","author":"Teachey","year":"2013","journal-title":"Br J Haematol"},{"issue":"4","key":"2024031115352833700_bib7","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrg3162","article-title":"MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship","volume":"13","author":"Pasquinelli","year":"2012","journal-title":"Nat Rev Genet"},{"key":"2024031115352833700_bib8","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of microRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2024031115352833700_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3390\/cancers15020428","article-title":"The importance of selected dysregulated microRNAs in diagnosis and prognosis of childhood B-cell precursor acute lymphoblastic leukemia","volume":"15","author":"Zi\u0119tara","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"16","key":"2024031115352833700_bib10","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.3390\/cancers14163976","article-title":"MicroRNAs and the diagnosis of childhood acute lymphoblastic leukemia: systematic review, meta-analysis and re-analysis with novel small RNA-seq tools","volume":"14","author":"Kyriakidis","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"35","key":"2024031115352833700_bib11","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1200\/JCO.2017.74.7451","article-title":"MicroRNA expression-based model indicates event-free survival in pediatric acute myeloid leukemia","volume":"35","author":"Lim","year":"2017","journal-title":"J\u00a0Clin Oncol"},{"issue":"20","key":"2024031115352833700_bib12","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1200\/JCO.2015.62.4544","article-title":"Dexamethasone and high-dose methotrexate improve outcome for children and young adults with high-risk B-acute lymphoblastic leukemia: a report from Children\u2019s Oncology Group Study AALL0232","volume":"34","author":"Larsen","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"2024031115352833700_bib13","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.19.01086","article-title":"Outcome in children with standard-risk B-cell acute lymphoblastic leukemia: results of Children\u2019s Oncology Group trial AALL0331","volume":"38","author":"Maloney","year":"2020","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"2024031115352833700_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41408-020-0287-4","article-title":"Risk-adjusted therapy for pediatric non-T cell ALL improves outcomes for standard risk patients: results of JACLS ALL-02","volume":"10","author":"Hasegawa","year":"2020","journal-title":"Blood Cancer J"},{"issue":"1","key":"2024031115352833700_bib15","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/s12185-018-2440-4","article-title":"Treatment outcome of children with acute lymphoblastic leukemia: the Tokyo Children\u2019s Cancer Study Group (TCCSG) study L04-16","volume":"108","author":"Takahashi","year":"2018","journal-title":"Int J Hematol"},{"issue":"3","key":"2024031115352833700_bib16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41587-020-0439-x","article-title":"The nf-core framework for community-curated bioinformatics pipelines","volume":"38","author":"Ewels","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"1","key":"2024031115352833700_bib17","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13059-020-02043-x","article-title":"CICERO: a versatile method for detecting complex and diverse driver fusions using cancer RNA sequencing data","volume":"21","author":"Tian","year":"2020","journal-title":"Genome Biol"},{"issue":"23","key":"2024031115352833700_bib18","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1182\/blood-2009-08-239681","article-title":"Identification of novel cluster groups in pediatric high-risk B-precursor acute lymphoblastic leukemia with gene expression profiling: correlation with genome-wide DNA copy number alterations, clinical characteristics, and outcome","volume":"116","author":"Harvey","year":"2010","journal-title":"Blood"},{"issue":"7633","key":"2024031115352833700_bib19","first-page":"433","article-title":"A\u00a017-gene stemness score for rapid determination of risk in acute leukaemia","volume":"540","author":"Ng","year":"2016","journal-title":"Nature 2016"},{"issue":"11","key":"2024031115352833700_bib20","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1038\/leu.2017.80","article-title":"Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN\/Ikaros\/miR-26b mechanism reveals a critical targetable role for PIK3CD","volume":"31","author":"Yuan","year":"2017","journal-title":"Leukemia"},{"issue":"5","key":"2024031115352833700_bib21","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.3892\/or.2016.5117","article-title":"MicroRNA-101 regulates T-cell acute lymphoblastic leukemia progression and chemotherapeutic sensitivity by targeting Notch1","volume":"36","author":"Qian","year":"2016","journal-title":"Oncol Rep"},{"issue":"21","key":"2024031115352833700_bib22","doi-asserted-by":"crossref","first-page":"4992","DOI":"10.1182\/blood-2011-10-385716","article-title":"MicroRNA-29a and microRNA-142-3p are regulators of myeloid differentiation and acute myeloid leukemia","volume":"119","author":"Wang","year":"2012","journal-title":"Blood"},{"issue":"23","key":"2024031115352833700_bib23","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1182\/bloodadvances.2018017954","article-title":"Ablation of miR-146b in mice causes hematopoietic malignancy","volume":"2","author":"Mitsumura","year":"2018","journal-title":"Blood Adv"},{"issue":"6","key":"2024031115352833700_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jjco\/hyaa025","article-title":"Simultaneous changes in expression levels of BAALC and miR-326: a novel prognostic biomarker for childhood ALL","volume":"50","author":"Ghodousi","year":"2020","journal-title":"Jpn J Clin Oncol"},{"issue":"21","key":"2024031115352833700_bib25","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood.2020006610","article-title":"miR-130b and miR-128a are essential lineage-specific codrivers of t(4;11) MLL-AF4 acute leukemia","volume":"138","author":"Malouf","year":"2021","journal-title":"Blood"},{"issue":"19","key":"2024031115352833700_bib26","doi-asserted-by":"crossref","first-page":"4486","DOI":"10.1182\/blood-2011-09-378687","article-title":"The miR-17-92 cluster expands multipotent hematopoietic progenitors whereas imbalanced expression of its individual oncogenic miRNAs promotes leukemia in mice","volume":"119","author":"Li","year":"2012","journal-title":"Blood"},{"issue":"12","key":"2024031115352833700_bib27","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1182\/blood-2008-01-132837","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children\u2019s Oncology Group study","volume":"111","author":"Borowitz","year":"2008","journal-title":"Blood"},{"issue":"8","key":"2024031115352833700_bib28","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1182\/blood-2015-03-633685","article-title":"Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children\u2019s Oncology Group study AALL0232","volume":"126","author":"Borowitz","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2024031115352833700_bib29","first-page":"1","article-title":"Regularization paths for generalized linear models via coordinate descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J\u00a0Stat Softw"},{"issue":"11","key":"2024031115352833700_bib30","doi-asserted-by":"crossref","first-page":"e828","DOI":"10.1016\/S2352-3026(21)00304-5","article-title":"Defining low-risk high hyperdiploidy in patients with paediatric acute lymphoblastic leukaemia: a retrospective analysis of data from the UKALL97\/99 and UKALL2003 clinical trials","volume":"8","author":"Enshaei","year":"2021","journal-title":"Lancet Haematol"},{"issue":"2","key":"2024031115352833700_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/hep.32356","article-title":"Metastatic tumor antigen 1 contributes to hepatocarcinogenesis posttranscriptionally through RNA-binding function","volume":"77","author":"Li","year":"2023","journal-title":"Hepatology"},{"issue":"28","key":"2024031115352833700_bib32","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1038\/onc.2016.491","article-title":"MTA1 modulated by miR-30e contributes to epithelial-to-mesenchymal transition in hepatocellular carcinoma through an ErbB2-dependent pathway","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"2024031115352833700_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-Seq data","volume":"14","author":"H\u00e4nzelmann","year":"2013","journal-title":"BMC Bioinformatics"},{"issue":"9","key":"2024031115352833700_bib34","doi-asserted-by":"crossref","first-page":"e0162638","DOI":"10.1371\/journal.pone.0162638","article-title":"The expression pattern of the pre-B cell receptor components correlates with cellular stage and clinical outcome in acute lymphoblastic leukemia","volume":"11","author":"Chen","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"2024031115352833700_bib35","doi-asserted-by":"crossref","first-page":"6843","DOI":"10.1038\/s41467-021-27232-5","article-title":"Single-cell analysis identifies dynamic gene expression networks that govern B cell development and transformation","volume":"12","author":"Lee","year":"2021","journal-title":"Nat Commun"},{"issue":"5","key":"2024031115352833700_bib36","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.cell.2008.02.020","article-title":"Dicer ablation affects antibody diversity and cell survival in the B lymphocyte lineage","volume":"132","author":"Koralov","year":"2008","journal-title":"Cell"},{"issue":"5","key":"2024031115352833700_bib37","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/2159-8290.CD-20-1230","article-title":"St. Jude Cloud: a pediatric cancer genomic data-sharing ecosystem","volume":"11","author":"McLeod","year":"2021","journal-title":"Cancer Discov"},{"issue":"1","key":"2024031115352833700_bib38","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1038\/s41467-019-11610-1","article-title":"Cancer-associated mutations in DICER1 RNase IIIa and IIIb domains exert similar effects on miRNA biogenesis","volume":"10","author":"Vedanayagam","year":"2019","journal-title":"Nat Commun"},{"issue":"11","key":"2024031115352833700_bib39","doi-asserted-by":"crossref","first-page":"eabd6280","DOI":"10.1126\/sciadv.abd6280","article-title":"Oxidative phosphorylation enhances the leukemogenic capacity and resistance to chemotherapy of B cell acute lymphoblastic leukemia","volume":"7","author":"Chen","year":"2021","journal-title":"Sci Adv"},{"issue":"10","key":"2024031115352833700_bib40","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/nrc3802","article-title":"DICER1: mutations, microRNAs and mechanisms","volume":"14","author":"Foulkes","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"50","key":"2024031115352833700_bib41","doi-asserted-by":"crossref","first-page":"E11711","DOI":"10.1073\/pnas.1814397115","article-title":"Transcriptional landscape of B cell precursor acute lymphoblastic leukemia based on an international study of 1,223 cases","volume":"115","author":"Li","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"2024031115352833700_bib42","first-page":"4764","article-title":"A\u00a0microRNA signature for clinical outcomes of pediatric ALL patients treated with TPOG protocols","volume":"12","author":"Chang","year":"2022","journal-title":"Am J Cancer Res"},{"issue":"4","key":"2024031115352833700_bib43","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10555-019-09826-0","article-title":"MicroRNA as a prognostic biomarker for survival in childhood acute lymphoblastic leukemia: a systematic review","volume":"38","author":"Rashed","year":"2019","journal-title":"Cancer Metastasis Rev"},{"issue":"12","key":"2024031115352833700_bib44","doi-asserted-by":"crossref","first-page":"4212","DOI":"10.1016\/j.celrep.2019.11.078","article-title":"Comparison of reproducibility, accuracy, sensitivity, and specificity of miRNA quantification platforms","volume":"29","author":"Godoy","year":"2019","journal-title":"Cell Rep"},{"issue":"12","key":"2024031115352833700_bib45","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1200\/JCO.2017.74.3617","article-title":"IKZF1 plus defines a new minimal residual disease-dependent very-poor prognostic profile in pediatric b-cell precursor acute lymphoblastic leukemia","volume":"36","author":"Stanulla","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"10","key":"2024031115352833700_bib46","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1001\/jamaoncol.2021.2723","article-title":"Association of combined focal 22q11.22 deletion and IKZF1 alterations with outcomes in childhood acute lymphoblastic leukemia","volume":"7","author":"Mangum","year":"2021","journal-title":"JAMA Oncol"},{"issue":"9","key":"2024031115352833700_bib47","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1001\/jama.2021.0987","article-title":"Effect of blinatumomab vs chemotherapy on event-free survival among children with high-risk first-relapse B-cell acute lymphoblastic leukemia: a randomized clinical trial","volume":"325","author":"Locatelli","year":"2021","journal-title":"JAMA"},{"issue":"1","key":"2024031115352833700_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13045-021-01111-4","article-title":"MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies","volume":"14","author":"Ahmadi","year":"2021","journal-title":"J\u00a0Hematol Oncol"},{"issue":"21","key":"2024031115352833700_bib49","first-page":"11357","article-title":"Aberrant splicing in B-cell acute lymphoblastic leukemia","volume":"46","author":"Black","year":"2018","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2024031115352833700_bib50","doi-asserted-by":"crossref","first-page":"zcac041","DOI":"10.1093\/narcan\/zcac041","article-title":"A\u00a0convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1","volume":"4","author":"Closa","year":"2022","journal-title":"NAR Cancer"},{"issue":"1","key":"2024031115352833700_bib51","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1038\/s41467-018-06063-x","article-title":"Aberrant splicing and defective mRNA production induced by somatic spliceosome mutations in myelodysplasia","volume":"9","author":"Shiozawa","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"2024031115352833700_bib52","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13058-022-01593-1","article-title":"Towards resolution of the intron retention paradox in breast cancer","volume":"24","author":"Shah","year":"2022","journal-title":"Breast Cancer Res"},{"issue":"3","key":"2024031115352833700_bib53","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/nar\/gkz1180","article-title":"Dynamic changes in intron retention are tightly associated with regulation of splicing factors and proliferative activity during B-cell development","volume":"48","author":"Ullrich","year":"2020","journal-title":"Nucleic Acids Res"},{"issue":"7569","key":"2024031115352833700_bib54","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/nature14985","article-title":"The spliceosome is a therapeutic vulnerability in MYC-driven cancer","volume":"525","author":"Hsu","year":"2015","journal-title":"Nature"},{"issue":"15","key":"2024031115352833700_bib55","doi-asserted-by":"crossref","first-page":"7132","DOI":"10.1158\/0008-5472.CAN-07-0750","article-title":"Identification of Pax5 as a target of MTA1 in B-cell lymphomas","volume":"67","author":"Balasenthil","year":"2007","journal-title":"Cancer Res"},{"issue":"3","key":"2024031115352833700_bib56","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.ccell.2015.02.003","article-title":"Self-enforcing feedback activation between BCL6 and Pre-B cell receptor signaling defines a distinct subtype of acute lymphoblastic leukemia","volume":"27","author":"Geng","year":"2015","journal-title":"Cancer Cell"},{"issue":"9","key":"2024031115352833700_bib57","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1182\/blood-2016-06-722900","article-title":"Ibrutinib inhibits pre-BCR+ B-cell acute lymphoblastic leukemia progression by targeting BTK and BLK","volume":"129","author":"Kim","year":"2017","journal-title":"Blood"},{"issue":"3","key":"2024031115352833700_bib58","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/s41375-022-01806-8","article-title":"Whole genome sequencing provides comprehensive genetic testing in childhood B-cell acute lymphoblastic leukaemia","volume":"37","author":"Ryan","year":"2023","journal-title":"Leukemia"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/5\/1258\/2217584\/blooda_adv-2023-011583-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/5\/1258\/2217584\/blooda_adv-2023-011583-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T15:36:16Z","timestamp":1710171376000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/5\/1258\/506682\/RNA-seq-based-miRNA-signature-as-an-independent"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,5]]},"references-count":58,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,3,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023011583","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,5]]}}}